IGC Pharma
IGC Pharma develops cannabinoid-based therapies like IGC-AD1 for treating agitation in Alzheimer's patients and utilizes AI for early disease detection.
Specifications
- LocationMaryland, USA
- Content Platform
- Colors
IGC Pharma develops cannabinoid-based therapies like IGC-AD1 for treating agitation in Alzheimer's patients and utilizes AI for early disease detection.
